1. A low repair endotype is predictive for response to FGF-18 treatment: data from the phase II oa forward study. (April 2021) Authors: Bay-Jensen, A.-C; Manginelli, A.; Karsdal, M.A.; Luo, Y.; He, Y.; Michaelis, M.; Guehring, H.; Ladel, C. Journal: Osteoarthritis and cartilage Issue: Volume 29(2021)Supplement 1 Page Start: S144 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ADAMTS-5 degraded cartilage increases tissue turnover in synovial membrane explants and stimulation is inhibited by the anti ADAMTS-5 nanobody, M6495. Issue 1 (April 2020) Authors: Sharma, N.; Bay-Jensen, A.-C.; Hector, H.S.; Gantzel, T.; Michaelis, M.; Ladel, C.; Karsdal, M.A.; Lindemann, S.; Thudium, C.S. Journal: Osteoarthritis and cartilage Issue: Volume 28:Issue 1(2020)supplement Page Start: S118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Articular cartilage from osteoarthritis patients shows extracellular matrix remodeling over the course of treatment with Sprifermin (recombinanant human fibroblast growth factor 18). (April 2018) Authors: Reker, D.; Thudium, C.S.; Sofie Siebuhr, A.; Gantzel, T.; Ladel, C.; Michaelis, M.; Karsdal, M.A.; Gigout, A.; Bay-Jensen, A.C. Journal: Osteoarthritis and cartilage Issue: Volume 26(2018)Supplement 1 Page Start: S43 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Chondrocyte pro-proliferative compounds may utilize extracellular matrix remodeling processes to regenerate cartilage. (April 2016) Authors: Reker, D.; Kjelgaard-Petersen, C.; Gigout, A.; Ladel, C.; Siebuhr, A.; Michaelis, M.; Karsdal, M.; Bay-Jensen, A. Journal: Osteoarthritis and cartilage Issue: Volume 24(2016)Supplement 1 Page Start: S157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Disease-modifying treatments for osteoarthritis (DMOADs) of the knee and hip: lessons learned from failures and opportunities for the future. Issue 12 (December 2016) Authors: Karsdal, M.A.; Michaelis, M.; Ladel, C.; Siebuhr, A.S.; Bihlet, A.R.; Andersen, J.R.; Guehring, H.; Christiansen, C.; Bay-Jensen, A.C.; Kraus, V.B. Journal: Osteoarthritis and cartilage Issue: Volume 24:Issue 12(2016) Page Start: 2013 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effects of three potential anabolic disease-modifying osteoarthritis drugs – sprifermin, IGF1 and BMP7 – on matrix production and the phenotype of articular chondrocytes. (April 2019) Authors: Mueller, S.; Michaelis, M.; Lindemann, S.; Gigout, A. Journal: Osteoarthritis and cartilage Issue: Volume 27(2019)Supplement 1 Page Start: S156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Elevated levels of CRPM, an inflammatory biomarker correlating with disease activity in RA, are prognostic of radiographic knee OA. (April 2017) Authors: Bay-Jensen, A.-C.; Bihlet, A.; Byrjalsen, I.; Andersen, J.; He, Y.; Siebuhr, A.; Thudium, C.; Guehring, H.; Michaelis, M.; Ladel, C.; Juel Riis, B.; Christiansen, C.; Karsdal, M.A. Journal: Osteoarthritis and cartilage Issue: Volume 25(2017)Supplement 1 Page Start: S83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Enzastaurin inhibits ABCB1-mediated drug efflux independently of effects on protein kinase C signalling and the cellular p53 status. (December 2016) Authors: Michaelis, M.; Rothweiler, F.; Loeschmann, N.; Sharifi, M.; Ghafourian, T.; Cinatl, J. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Enzastaurin inhibits ABCB1-mediated drug efflux independently of effects on protein kinase C signalling and the cellular p53 status. (July 2016) Authors: Michaelis, M.; Rothweiler, F.; Löschmann, N.; Sharifi, M.; Ghafourian, T.; Cinatl, J. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Flubendazole as potential anti-neuroblastoma therapy option. (December 2016) Authors: Michaelis, M.; Agha, B.; Rothweiler, F.; Loeschmann, N.; Voges, Y.; Westermann, F.; Wass, M.; Cinatl, J. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗